SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-056138
Filing Date
2012-10-15
Accepted
2012-10-15 16:06:58
Documents
13
Period of Report
2012-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v323942_10k.htm 10-K 3001650
2 EXHIBIT 21 v323942_ex21.htm EX-21 4508
3 EXHIBIT 23 v323942_ex23.htm EX-23 3159
4 CERTIFICATION v323942_ex31-1.htm EX-31.1 9151
5 CERTIFICATION v323942_ex31-2.htm EX-31.2 9197
6 CERTIFICATION v323942_ex32.htm EX-32 4133
13 GRAPHIC tpg28.jpg GRAPHIC 53534
  Complete submission text file 0001144204-12-056138.txt   14236491

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gnbt-20120731.xml EX-101.INS 1814769
8 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20120731.xsd EX-101.SCH 183164
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20120731_cal.xml EX-101.CAL 57182
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20120731_def.xml EX-101.DEF 539902
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20120731_lab.xml EX-101.LAB 1095983
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20120731_pre.xml EX-101.PRE 670591
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 121143921
SIC: 2834 Pharmaceutical Preparations